US: Investing in nutraceuticals "worthwhile" - research
By just-drinks.com editorial team | 23 April 2010
Investing in the ability to claim that a food or drink product has health benefits is a "worthwhile" process, despite costs of over US$10m, according to research.
just-drinks articles are only available to registered users and members.
Join now for increased access
There are various access options to choose from. All provide instant access to the latest news, insight and expert analysis.
If you’re already a member, login here.
Investing in the ability to claim that a food or drink product has health benefits is a "worthwhile" process, despite costs of over US$10m, according to research.
- Unlimited access to all the latest global beverage news and insight
- Expert analysis that puts the news into context
- Exclusive interviews with leading industry figures
- Monthly management briefings with detailed analysis on hot topics
- Personalised RSS feeds and email newsletters
- 10-year archive of news, insight and intelligence
- Discounts on just-drinks market research
- Plus much more
If you’re already a member, login here
More articles related to this one
Update - EUROPE: Weather boosts Nestle, Danone water sales - analyst
Good weather in Europe helped bottled water rivals Danone and Nestle to report "unusually strong" results for the third quarter of 2010, an analyst has said.
FRANCE: Danone Waters Q3 sales up, confirms FY guidance
Danone Waters has posted an increase in third-quarter sales and confirmed its full-year targets for growth.
Update - EUROPE: Yakult to continue probiotic studies despite EFSA doubts
Japanese dairy firm Yakult has said it will continue to conduct human studies to back-up the health benefits of its probiotic products, after the European Food Safety Authority (EFSA) cast doubt on health claims for probiotics.
